Clinical Focus

  • Pediatric Emergency Medicine

Academic Appointments

  • Clinical Assistant Professor, Emergency Medicine
  • Clinical Assistant Professor, Pediatrics
  • Clinical Assistant Professor, Pediatrics

Professional Education

  • Board Certification: American Board of Pediatrics, Pediatric Emergency Medicine (2021)
  • Fellowship: NYU Bellevue Hospital Pediatric Emergency Medicine Fellowship (2019) NY
  • Board Certification: American Board of Pediatrics, Pediatrics (2015)
  • Residency: Cornell University Pediatric Residency (2015) NY
  • Medical Education: Medical University of South Carolina Registrar (2012) SC

Contact

  • Academic
    gadeangu@stanford.edu
    University - Academic staff Department: Emergency Medicine - Adult Clinical/Academic Position: Clinical Assistant Professor
  • Clinical Stanford Dept of Emergency Medicine 500 Pasteur Dr Stanford, CA 94305 (650) 723-0121 (fax)
  • Clinical Stanford Emergency Department 900 Welch Rd Ste 350 Stanford, CA 94305 (650) 723-0121 (fax)

Additional Info

  • Mail Code: 5768

All Publications

  • Prevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With SARS-CoV-2. JAMA network open Aronson, P. L., Louie, J. P., Kerns, E., Jennings, B., Magee, S., Wang, M. E., Gupta, N., Kovaleski, C., McDaniel, L. M., McDaniel, C. E. 2023; 6 (5): e2313354

    Abstract

    The prevalence of urinary tract infection (UTI), bacteremia, and bacterial meningitis in febrile infants with SARS-CoV-2 is largely unknown. Knowledge of the prevalence of these bacterial infections among febrile infants with SARS-CoV-2 can inform clinical decision-making.To describe the prevalence of UTI, bacteremia, and bacterial meningitis among febrile infants aged 8 to 60 days with SARS-CoV-2 vs without SARS-CoV-2.This multicenter cross-sectional study was conducted as part of a quality improvement initiative at 106 hospitals in the US and Canada. Participants included full-term, previously healthy, well-appearing infants aged 8 to 60 days without bronchiolitis and with a temperature of at least 38 °C who underwent SARS-CoV-2 testing in the emergency department or hospital between November 1, 2020, and October 31, 2022. Statistical analysis was performed from September 2022 to March 2023.SARS-CoV-2 positivity and, for SARS-CoV-2-positive infants, the presence of normal vs abnormal inflammatory marker (IM) levels.Outcomes were ascertained by medical record review and included the prevalence of UTI, bacteremia without meningitis, and bacterial meningitis. The proportion of infants who were SARS-CoV-2 positive vs negative was calculated for each infection type, and stratified by age group and normal vs abnormal IMs.Among 14 402 febrile infants with SARS-CoV-2 testing, 8413 (58.4%) were aged 29 to 60 days; 8143 (56.5%) were male; and 3753 (26.1%) tested positive. Compared with infants who tested negative, a lower proportion of infants who tested positive for SARS-CoV-2 had UTI (0.8% [95% CI, 0.5%-1.1%]) vs 7.6% [95% CI, 7.1%-8.1%]), bacteremia without meningitis (0.2% [95% CI, 0.1%-0.3%] vs 2.1% [95% CI, 1.8%-2.4%]), and bacterial meningitis (<0.1% [95% CI, 0%-0.2%] vs 0.5% [95% CI, 0.4%-0.6%]). Among infants aged 29 to 60 days who tested positive for SARS-CoV-2, 0.4% (95% CI, 0.2%-0.7%) had UTI, less than 0.1% (95% CI, 0%-0.2%) had bacteremia, and less than 0.1% (95% CI, 0%-0.1%) had meningitis. Among SARS-CoV-2-positive infants, a lower proportion of those with normal IMs had bacteremia and/or bacterial meningitis compared with those with abnormal IMs (<0.1% [0%-0.2%] vs 1.8% [0.6%-3.1%]).The prevalence of UTI, bacteremia, and bacterial meningitis was lower for febrile infants who tested positive for SARS-CoV-2, particularly infants aged 29 to 60 days and those with normal IMs. These findings may help inform management of certain febrile infants who test positive for SARS-CoV-2.

    View details for DOI 10.1001/jamanetworkopen.2023.13354

    View details for PubMedID 37171815